A 5-year-old boy with chronic granulomatous disease (CGD) was treated with amphotericin B for an invasive pulmonary Aspergillus nidulans infection. The infection progressed during 6 wk of treatment despite the addition of interferon- γ (IFN- γ ), filgrastim, and transfusions with donor granulocytes. Treatment with a novel antifungal triazole, voriconazole, resulted in an excellent clinical response. van ‘t Hek LG, Verweij PE, Weemaes CM, van Dalen R, Yntema J-B, Meis JF. Successful treatment with voriconazole of invasive aspergillosis in chronic granulomatous disease.
No takes yet. Share an insight, caveat, or question.
HEK et al. (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: